These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17394939)

  • 1. Long-term outcomes: what should the focus be?
    Aschner JL; Walsh MC
    Clin Perinatol; 2007 Mar; 34(1):205-17, ix. PubMed ID: 17394939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myth: all surfactants are alike.
    Moya F; Javier MC
    Semin Fetal Neonatal Med; 2011 Oct; 16(5):269-74. PubMed ID: 21515101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To tube or not to tube babies with respiratory distress syndrome.
    Sekar KC; Corff KE
    J Perinatol; 2009 May; 29 Suppl 2():S68-72. PubMed ID: 19399013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades?
    Mugford M
    Early Hum Dev; 2006 Feb; 82(2):105-15. PubMed ID: 16457971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of bronchopulmonary dysplasia after participation in the Breathsavers Group of the Vermont Oxford Network Neonatal Intensive Care Quality Improvement Collaborative.
    Payne NR; LaCorte M; Karna P; Chen S; Finkelstein M; Goldsmith JP; Carpenter JH;
    Pediatrics; 2006 Nov; 118 Suppl 2():S73-7. PubMed ID: 17079626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of natural surfactants to prevent and treat respiratory distress syndrome.
    Spafford PS; Kendig JW; Maniscalco WM
    Semin Perinatol; 1993 Aug; 17(4):285-94. PubMed ID: 8140443
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of surfactant for respiratory distress syndrome.
    Mallamo K
    Neonatal Netw; 1999 Oct; 18(7):43. PubMed ID: 10808888
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal-derived surfactants versus past and current synthetic surfactants: current status.
    Moya F; Maturana A
    Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?
    Sinha S; Moya F; Donn SM
    Curr Opin Pediatr; 2007 Apr; 19(2):150-4. PubMed ID: 17496757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled nitric oxide in the premature newborn.
    Kinsella JP; Abman SH
    J Pediatr; 2007 Jul; 151(1):10-5. PubMed ID: 17586183
    [No Abstract]   [Full Text] [Related]  

  • 12. Bubble continuous positive airway pressure, a potentially better practice, reduces the use of mechanical ventilation among very low birth weight infants with respiratory distress syndrome.
    Nowadzky T; Pantoja A; Britton JR
    Pediatrics; 2009 Jun; 123(6):1534-40. PubMed ID: 19482765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchopulmonary dysplasia. Impact of surfactant replacement therapy.
    McColley SA
    Pediatr Clin North Am; 1998 Jun; 45(3):573-86. PubMed ID: 9653437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis.
    Merritt TA; Hallman M; Vaucher Y; McFeeley E; Tubman TR
    J Perinatol; 1990 Dec; 10(4):416-9. PubMed ID: 2126034
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic consequences of surfactant therapy.
    Eidelman AI
    J Perinatol; 1993; 13(2):137-9. PubMed ID: 8515307
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous positive airway pressure and surfactant.
    Bohlin K; Jonsson B; Gustafsson AS; Blennow M
    Neonatology; 2008; 93(4):309-15. PubMed ID: 18525215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
    Fernandes CJ; Horst DA; O'Donovan DJ
    J Perinatol; 2005 May; 25(5):361-2; author reply 363. PubMed ID: 15861205
    [No Abstract]   [Full Text] [Related]  

  • 20. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.
    Donn SM; Dalton J
    Respir Care; 2009 Sep; 54(9):1203-8. PubMed ID: 19712497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.